Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer

被引:17
|
作者
Nakamura, Ryota [2 ]
Kurishima, Koichi [3 ]
Kobayashi, Naohiro [2 ]
Ishikawa, Shigemi [2 ]
Goto, Yukinobu [2 ]
Sakai, Mitsuaki [2 ]
Onizuka, Masataka [2 ]
Ishikawa, Hiroichi [4 ]
Satoh, Hiroaki [1 ,3 ]
Hizawa, Nobuyuki [3 ]
Sato, Yukio [2 ]
机构
[1] Univ Tsukuba, Mito Med Ctr, Dept Internal Med, Mito, Ibaraki 3100015, Japan
[2] Univ Tsukuba, Div Cardiovasc Thorac Surg, Mito, Ibaraki 3100015, Japan
[3] Univ Tsukuba, Inst Clin Med, Mito, Ibaraki 3100015, Japan
[4] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan
来源
ONKOLOGIE | 2010年 / 33卷 / 1-2期
关键词
Non-small cell lung cancer; Surgery; Postoperative; Follow-up; Prognosis; SURVIVAL; QUALITY; CARE; SURVEILLANCE; COMORBIDITY; PHYSICIANS; RESECTION; SURGERY; INDEX; SCORE;
D O I
10.1159/000264623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear whether postoperative follow-up by thoracic surgeons or chest physicians for non-small cell lung cancer (NSCLC) alters survival. Patients and Methods: The charts of 1,398 NSCLC patients, diagnosed between 1980 and 2008, were reviewed. Prognostic factors contained therein were evaluated using univariate and multivariate analyses. Patients were divided into 2 groups according to the doctor in charge of their postoperative follow-up: the thoracic surgeon group and the chest physician group. The doctors in charge of following up the patients were also analyzed for prognostic significance. Results: In the univariate and multivariate analyses, age 65 years or younger, female sex, early pathological stage, Charlson Index score of 0-1, absence of adjuvant therapy, and follow-up by a chest physician were significantly favorable prognostic factors. Examined overall, NSCLC patients in the chest physician group had longer survival than those in the thoracic surgeon group. The difference in survival of patients with advanced disease was also statistically significant between these 2 groups. Conclusions: Our results indicate that early detection of asymptomatic disease by regular follow-up including chest computed tomography scan may improve the chance of treatment with curative intent and thus may increase survival, irrespective of the doctor in charge of follow-up.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [41] Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Planchard, D.
    Popat, S.
    Kerr, K.
    Novello, S.
    Smit, E. F.
    Faivre-Finn, C.
    Mok, T. S.
    Reck, M.
    Van Schil, P. E.
    Hellmann, M. D.
    Peters, S.
    ANNALS OF ONCOLOGY, 2018, 29 : 192 - 237
  • [42] Follow-up Analysis Enhances Understanding of Molecular Residual Disease in Localized Non-Small Cell Lung Cancer
    Zhang, Jia-Tao
    Liu, Si-Yang
    Gao, Xuan
    Liu, Si-Yang Maggie
    Yan, Bingfa
    Huang, Chen
    Jiao, Zicong
    Yan, Hong-Hong
    Pan, Yi
    Dong, Song
    Gao, Wei
    Gong, Yuhua
    Tu, Hai-Yan
    Xia, Xue-Feng
    Zhou, Qing
    Zhong, Wen-Zhao
    Yang, Xue-Ning
    Yi, Xin
    Wu, Yi-Long
    CLINICAL CANCER RESEARCH, 2025, 31 (07) : 1305 - 1314
  • [43] Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer
    Weitberg, AB
    Liu, L
    Yashar, J
    Glicksman, AS
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2001, 20 (03): : 335 - 340
  • [44] Alternative Follow-Up Methods Based on Recurrence Patterns after Surgery for Non-Small Cell Lung Cancer
    Watanabe, Katsuya
    Sakamaki, Kentaro
    Nishii, Teppei
    Gorai, Atsuo
    Yamamoto, Taketsugu
    Nagashima, Takuya
    Ando, Kohei
    Ishikawa, Yoshihiro
    Woo, Tetsukan
    Adachi, Hiroyuki
    Kumakiri, Yutaka
    Maehara, Takamitsu
    Nakayama, Haruhiko
    Masuda, Munetaka
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S245 - S246
  • [45] Neoadjuvantnivolumab in resectable non-small cell lung cancer: Extended follow-up and molecular markers of response.
    Reuss, Joshua E.
    Smith, Kellie Nicole
    Anagnostou, Valsamo
    Zhang, Jiajia
    Zahurak, Marianna
    Caushi, Justina
    Chan, Hok Yee
    Guo, Haidan
    Hellmann, Matthew David
    Pardoll, Drew M.
    Brahmer, Julie R.
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [46] Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer
    Yano, Tokujiro
    Okamoto, Tatsuro
    Fukuyama, Seiichi
    Maehara, Yoshihiko
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (05): : 1048 - 1054
  • [47] Anesthetic predictors for postoperative pneumonia in patients with non-small cell lung cancer
    Zhu, Wenzhi
    Zhu, Liping
    Li, Shuang
    Wang, Xiaoyi
    Tan, Hongyu
    JOURNAL OF THORACIC DISEASE, 2024, 16 (05) : 3204 - 3212
  • [48] Treatment and survival in patients with postoperative recurrence of non-small cell lung cancer
    Nakajima, Ryu
    Izumi, Nobuhiro
    Takahama, Makoto
    Yamamoto, Ryoji
    Tada, Hirohito
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S857 - S857
  • [49] Postoperative treatment in margin positive patients of non-small cell lung cancer
    Sawabata, Noriyoshi
    Kawaguchi, Takeshi
    Yasukawa, Motoaki
    Kawai, Norikazu
    Taniguchi, Shigeki
    VIDEO-ASSISTED THORACIC SURGERY, 2018, 3
  • [50] Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients
    Weigel, TL
    Kosco, PJ
    Dacic, S
    Rusch, VW
    Ginsberg, RJ
    Luketich, JD
    ANNALS OF THORACIC SURGERY, 2001, 71 (03): : 967 - 970